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Abstract: A personal selection of 32 recent papers is presented covering various 
aspects of current developments in bioorganic chemistry and novel natural products 
such as tryptorubin A isolated from a Streptomyces species. 
 
The structure of aspergicine 1, a metabolite obtained from the co-culture of two 
Aspergillus species isolated from the fruit of Avicennia marina, was established by X-
ray analysis.1 This work prompted the revision of the structure of the co-metabolite 
aspergicin from 2 to 3. Three racemic spiro indolinone-naphthofuran alkaloids, such 
as pratensilin A 4, have been isolated from cultures of a marine Streptomyces 
species.2 The authors propose biosynthetic pathways to the pratensilins from the 
angucyclinone co-metabolite 8-O-methylrabelomycin 5. 
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Melodinus yunnanensis is the source of the monoterpenoid indole alkaloid meloyine 
A 6 that has a novel hexacyclic skeleton.3 Clausoxamine 7, from seeds of Clausena 
lansium, also has a novel skeleton.4 The authors propose that clausoxamine 7 is 
formed from co-occurring lansiumamide B 8. A Streptomyces species, isolated from 
the bracket fungus Hymenochaete rubiginosa, produced the polycyclic peptide 
tryptorubin A 9.5 Genome sequencing identified the likely genes for the production of 
the linear hexapeptide backbone of trytorubin A 9 which is then modified with three 
side-chain linkages to give a rigid globular structure. 
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Lissodendoric acid A 10, from the sponge Lissodendoryx florida, has a novel 
manzamine-related alkaloid structure.6 A biosynthetic route from cyclostellettamine N 
11 to lissodendoric acid A 10 has been proposed. The polyketide trichothiazole A 12, 
a metabolite of a Trichodesmium cyanobacterium, features a thiazole ring, a terminal 
alkyne and two vinyl chlorides.7 The authors discuss possible biosynthetic routes to 
trichothiazole A 12. 
 The marine sponge Lamellodysidea herbacea produces several sesquiterpenoids 
including lamellodysidine A 13 that has a new skeleton.8 A biosynthetic pathway to 
lamellodysidine A 13 from dendrolasin 14 has been proposed. The new skeleton of 
daphnauranin A 15, from the roots of Daphne aurantiaca, is suggested to be formed 
from a guaiane sesquiterpenoid precursor.9 The structure of nicotabin A 16, from 
Nicotiana tabacum, was confirmed by X-ray analysis.10 Nicotabin A 16 is a 
sesquiterpenoid linked to a 6-carbon unit that is possibly derived from citric acid. A 
biosynthetic pathway has been proposed. 
 
Four closely-related dimeric sesquiterpenoids, including artemisian A 17, have been 
isolated from Artemisia argyi.11 The artemisians appear to be formed by a Diels-Alder 
cyclisation of guaiadiene and 1,10:4,5-disecoguaiene precursors. A Diels-Alder 
cyclisation is also thought to be involved in the formation of the dimeric clerodane 
diterpenoid bistinospinoside A 18 from Tinospora sagittata.12 
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Rhododendron molle is a rich source of grayanane diterpenoids. New examples 
include novel 2,3:5,6-diseco-derivatives such as rhodomollacetal A 19 whose 
structure was confirmed by X-ray analysis.13 The authors propose a biosynthetic 
pathway to rhodomollacetal A 19. The structure of pleurocin A 20, from fruiting 
bodies of Pleurotus eryngii, was also confrmed by X-ray analysis.14 Pleurocin A 20 is 
a novel 11(9→7)-abeo-ergostane steroid and a biosynthetic pathway for its formation 
has been suggested. 
 
Synthetic studies have been used to support the hypothesis that an intramolecular 
Diels-Alder cycloaddition is involved in the biosynthesis of the elansolids (such as 
A1/A2 21) from the gliding bacterium Chitinophaga sancti.15 Precursor labelling 
studies have demonstrated that 2-geranyl-1,4-naphthohydroquinone 22 is efficiently 
converted to 2-(4-methyl-3-penten-1-yl)anthraquinone 23 in Sesamum indicum and 
that 23 is also efficiently converted into 2-(4-methyl-1Z,3-pentadien-1-
yl)anthraquinone 24 but not into more highly oxygenated anthraquinone derivatives 
(Scheme 1).16 
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To improve substrate scope and reaction rates, molecular dynamic simulations have 
been used to study the recently identified thioesterase from the pikromycin 
biosynthetic pathway.17 This work has shown that a single active site mutation 
(S148C) that increases substrate flexibility can produce a more effective 
macrolactonisation catalyst, allowing the production of novel diastereomeric 
macrolactones (Scheme 2). The biosynthetic gene cluster of the epoxycyclohexenone 
macrophorins (e.g. macrophorin D 25) has been isolated and characterised from 
Penicillium terrestris.18 From this cluster, MacJ, a membrane-bound type-II terpene 
cyclase has been shown to cyclise meroterpenoids through direct olefinic bond 
protonation.  
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Biochemical and crystallographic analyses have revealed the role of the 
multifunctional enzyme, Trt14 from Aspergillus terreus, in the biosynthesis of the 
fungal meroterpenoid terretonin 26.19 As well as catalysing the D-ring expansion via 
intramolecular methoxy rearrangement, the enzyme is also involved in hydrolysis of 
the expanded D-ring. Activation of a cryptic gene cluster in Lysobacter enzymogenes 
that contains three nonribosomal peptide synthetases (NRPS) has led to the 
production of novel pyrrolopyrazines (e.g. 27).20 Targeted gene inactivation showed 
that these pyrrolopyrazines are synthesised by the NRPS via a module-domain 
portable mechanism. 
 
The dehydratase enzyme, Pac13 responsible for the conversion of uridine-5’-aldehyde 
to 3’-deoxy-3’,4’-didehydrouridine-5’-aldehyde (Scheme 3) during the biosynthesis 
of uridyl peptide antibiotics has been characterised.21 Studies have shown that an 
active site residue, histidine-42 is crucial for enzyme activity and that dehydration 
likely proceeds via an E1cB mechanism. Feeding studies with deuterium-labelled 
glycerols in Streptomyces calvus have provided insight into the biosynthesis of the 
antibiotic nucleocidin 28.22 In particular, deuterium incorporations from various 
glycerol isotopomers at the C-5’ site of nucleocidin indicate that there is no oxidation 
of the pro-R hydroxymethyl group of glycerol during the biosynthesis of the 
antibiotic. 
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An entirely novel biosynthetic pathway of the sulfur metabolite, ergothioneine 29 
from the anaerobic green sulfur bacterium Chlorobium limicola has been reported.23 
From this pathway, a sulfur transferase, EanB has been characterised and shown to 
convert N-α-trimethylhistidine to ergothioneine by transfer of sulfur to a non-
activated carbon. Characterisation of the biosynthetic pathway of the ergot alkaloid 
isofumigaclavine A 30 from the blue cheese-making fungus Penicillium roqueforti 
has led to the identification of a bifunctional old yellow enzyme (OYE) homologue 
involved in the production of the intermediate, festuclavine 31.24 Further studies 
showed that the OYE homologue also enhances the production of the preceding 
biosynthetic intermediate, chanoclavine-I aldehyde via activation of short-chain 
dehydrogenase/reductases. 
 The two-step biosynthetic conversion of thiotetromycin to thiotetramide C by tandem 
oxidation and amidation of a chemically inert alkyl group has been reported.25 The 
transformation which is mediated by a cytochrome P450-amidotransferase enzyme 
pair could be conducted as an in vitro chemoenzymatic reaction, resulting in the 
efficient preparation of thiotetroamide C (Scheme 4) and other unnatural bioactive 
analogues. The use of efficient recombinant E. coli whole-cells overexpressing 
aldoxamine dehydratases have been used as a new general approach for the synthesis 
of chiral nitriles.26 The study also discovered that the use of the E or Z isomer of a 
racemic aldoxamine substrate gave preferentially one or the other enantiomer with a 
particular enzyme (Scheme 5). 
Scheme 4
S
OH
O
S
OH
O
O NH2
TtmP, TtmO, Bmp10
TtmN, L-Gln, ATP, Mg2+
NADH, PtdH
phosphite, 80%
Scheme 5
Br
N
OH
Br
CN
whole cell catalyst
OxdFG
37% conv.
87% ee
Br
N
Br
CN
whole cell catalyst
OxdFG
51% conv.
88% ee
OH
 
Computational analysis has allowed the engineering of a ketoreductase CgKR1 from 
Candida glabrata, resulting in a high activity biocatalyst (CgKR1-F92C/F94W).27 
The engineered biocatalyst was used for the large scale synthesis of various chiral 
alcohols, such as (S)-N-Boc-3-hydroxypiperidine (Scheme 6), a key intermediate for 
the preparation of imbruvica, used in the treatment of lymphoma. A NADPH-
dependent reductive aminase from Aspergillus oryzae has been discovered that has 
particularly high activity for the reductive amination of ketones.28 X-Ray 
crystallography of the enzyme was used to inform mutagenesis studies, resulting in 
variant biocatalysts with a switch in stereoselectivity compared to the wild-type 
enzyme (Scheme 7). The wild-type enzyme and mutant variants were also used for the 
preparative-scale synthesis of various optically active amines. 
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Extensive analysis of a large number of imine reductases has identified various 
biocatalysts that are able to convert 1-aryl substituted dihydroisoquinolines to the 
corresponding R- or S-tetrahydroisoquinolines (THIQ) with high conversion and 
enantioselectivity.29 The potential of these biocatalysts was demonstrated with the 
synthesis of THIQs such as 32, used as a key intermediate for the preparation 
solifenacin (Scheme 8). Flavin-dependent ene-reductases have been discovered that 
can perform enantioselective radical dehalogenation reactions of α-bromo-α-aryl 
esters (Scheme 9).30 Mechanistic studies confirmed the role of flavin hydroquinone as 
the single electron reductant. 
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A tandem multi-component reaction catalysed by Candida antarctica lipase B for the 
preparation of 3,4-dihydropyrimidin-2(1H)-ones has been developed (Scheme 10).31 
The two-step process involves the lipase generation of acetaldehyde from vinyl 
acetate, followed by an enzyme-mediated Biginelli reaction with urea and a β-
dicarbonyl compound. A new tandem method for the preparation of 125I-labelled aryl 
compounds from anilines via stable diazonium salts has been reported.32 The resulting 
radioiodinated compounds can be used as single-photon emission computed 
tomography (SPECT) imaging agents, such as iomazenil 33, a SPECT tracer of 
central-type benzodiazepine receptors in brain tissue. 
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